- 00Days
- 00Hours
- 00Minutes
- 00Seconds
About ACTO
ACE CLINICAL TRIALS Oncology, 2025 provides a platform to discuss main trends, current challenges and futuristic advancements in clinical trials and clinical research occurring in pharma world. Senior-level experts from top pharma companies will be sharing their professional insights and experiences related to the new clinical trials formats, rare disease trials and their best approaches, patient safety perspectives, building and implementing data-driven site selection approaches, wearables clinical trials , risks and benefits from a scientific and an operational perspective and much more.
Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by making new business alliances. Through case studies, panel & roundtable breakout discussions and an active exhibit hall, the summit delivers the real-world experiences and best practices needed to optimize clinical trial innovation, planning and management.
It gives us a great pleasure in welcoming you to the ACE CLINICAL TRIALS ONCOLOGY, 2025. We look forward to seeing you there.
Why Attend
ACTO Thought Leaders
PAUL AGAPOW
Director |
GSK
HANNAH THURGUR
Senior Research Officer |
Drug Science
RASMUS HJORTH
Head of Communication |
James Lind Care
ERIC HAJJAR
Associate Director Medical Research Operations (former) |
Biogen
Solutions at ACTO
✔️ Bio Statistics
✔️ Central Laboratory Services
✔️ Clinical Data Management
✔️ Clinical Monitoring
✔️ Clinical Operations
✔️ Clinical Program Management
✔️ Clinical Research
✔️ Clinical Trial Management
✔️ Comparator Sourcing & Drug Procurement Services
✔️ Contract Research Organization
✔️ Development Operations
✔️ Device testing
✔️ eClinical Technologies
✔️ Electronic Data Capture
✔️ Statistical Programming
✔️ Global Project & site Management
✔️ Imaging Tools
✔️ Investigator Site Services
✔️ Logistics & Materials Handling
✔️ Medical Devices
✔️ Medical Testing
✔️ Medical Translation
✔️ Medical Writing & Simulation
✔️ Global Clinical Research & Development
✔️ Patient recruitment & Retention
✔️ Pharmacovigilance
✔️ Pharmacovigilance & Drug Safety
✔️ Quality Assurance
✔️ Regulatory Affairs
✔️ Statistical Programming
Who Will Attend
✔️ Chief Medical Officer
✔️ Chief Scientific officer
✔️ Clinical Development Head
✔️ Chief Patient Officer
✔️ VP and Head RWE Oncology
✔️ VP Clinical Oncology R&D
✔️ Director Clinical Research
✔️ Director Clinical Innovation
✔️ Director Digital Health
✔️ Director Patient Recruitment
✔️ Oncology Lead/Cancer Biologist
✔️ Oncology Lead Medical Science Liaison
✔️ Country Medical Leader Oncology
✔️ Head of Clinical Operations
✔️ Senior Oncologist
✔️ Patient Engagement in Research Coordinator
✔️ Director of Oncology Market Development
✔️ Director of Oncology Operations
✔️ Clinical Operations Director
✔️ Associate Director Oncology
✔️ Senior Oncology Clinical Trials Pharmacist
✔️ Senior Medical Manager Oncology
✔️ Director Business Technology Leader Oncology
Attendee Breakdown
Attendee Demographics
Agenda
✔️ 08:45 – 09:00 Chairman’s Welcome Remarks
✔️ 09:00 – 09:30 Presentation no.1:
AI-Driven Drug Repurposing for Oncology: Identifying Novel Cancer Treatments from Existing Drugs
- How AI is being applied in drug repurposing for cancer treatment
- Merging of AI with clinical data
- Hurdles in data integration, model validation, and getting regulatory approval
Buyers 2024 Pharma / Biotech
Our Sponsors
Our Partners
Media Partners
Venue - The Insurance Hall
The Insurance Hall has been the home of the UK conference industry for over 80 years. It is a prestigious and impressive event venue steeped in history, heritage and architectural significance, a hidden gem in one of the City of London’s most decorated buildings. A Grade II listed building formally opened by His Majesty King George V in 1934, The Insurance Hall offers exceptional and flexible event spaces for conferences, receptions, AGMs, business breakfasts, meetings, lunches and dinners for up to 300 people.
